Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition.
Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition. J Immunother Cancer. 2019 07 05; 7(1):169.
View in:
PubMed
subject areas
Aged
Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
Biomarkers
Carcinoma, Non-Small-Cell Lung
Cytokines
Fatal Outcome
Humans
Inflammation Mediators
Lung Neoplasms
Male
Neoplasm Metastasis
Neoplasm Staging
Neutropenia
authors with profiles
Abdulrafeh Naqash